Skip to main content
CUE
NASDAQ Life Sciences

Cue Biopharma Posts $50M Third-Quarter Loss

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$14.1
Mkt Cap
$102.428M
52W Low
$4.971
52W High
$45.5
52W Position info
184% above low
Off High info
69% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

CUE has more than doubled off its 52-week low of $4.971.

Summary

Cue Biopharma reported a $50M loss for its third quarter, a heavy burn for a company with a roughly $102M market cap. The red ink lands after a strong stretch: positive Phase 2 topline data for CUE-221 in chronic spontaneous urticaria in September sent shares up 51% premarket to $56.00, and the stock now sits at $14.10. Cash is the pressure point — the last 10-Q showed $17.4M on hand against a $153.1M net loss, backstopped by a July private placement that raised $49.8M and a $300M shelf with a $12.67M ATM. The loss figure alone doesn't say whether it includes non-cash items like warrant or milestone charges, so the 10-Q detail matters more than the headline number.

At the time of this announcement, CUE was trading at $14.10 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $102.4M. The 52-week trading range was $4.97 to $45.50. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

CUE - Latest Insights

CUE
Sep 21, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $47.67
Real-time Price: $13.83 info
Change: -$33.84 (-71%) info
Market Cap: $102.428M info
CUE
Sep 21, 2026, 6:59 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $61.10
Real-time Price: $13.83 info
Change: -$47.27 (-77%) info
Market Cap: $102.428M info
CUE
Sep 20, 2026, 6:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $37.63
Real-time Price: $13.83 info
Change: -$23.80 (-63%) info
Market Cap: $102.428M info
CUE
Aug 14, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $31.03
Real-time Price: $13.83 info
Change: -$17.20 (-55%) info
Market Cap: $102.428M info
CUE
Aug 14, 2026, 4:01 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $33.06
Real-time Price: $13.83 info
Change: -$19.23 (-58%) info
Market Cap: $102.428M info